All In MedTech

FDA Clearance Tracker · P030022-S039

REFLECTION CERAMIC ACETABULAR HIP SYSTEM (RCHS)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Mar 20, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P030022-S039
Device name
REFLECTION CERAMIC ACETABULAR HIP SYSTEM (RCHS)
Applicant location
Memphis, TN
Received
Sep 19, 2016
Decided
Mar 20, 2018
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P030022

Device type

Device class
Class III

Every decision under product code MRA

FDA's approval statement

As written in FDA's record.

Approval for the updated physician and patient labeling based on post approval study data.

Source documents

Other decisions for Smith & Nephew, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.